The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 4, 1999, Pages 799-808

  Sandirasegarane, Lakshman ^a,b   Diamond, Jack ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cyclic GMP; Nitric oxide (NO); ODQ; S nitroso N acetylpenicillamine (SNAP); Single cell contractility; Ventricular myocytes

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; CYCLIC GMP; GUANYLATE CYCLASE; ISOPRENALINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0033119294     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0919     Document Type: Article

References (37)

1. BALLIGAND JL, UNGUREANU D, KELLY RA, KOBZIK L, PIMENTAL D, MICHEL T, SMITH TW, 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91: 2314-2319.
2. BRADY AJB, WARREN JB, POOLE-WILSON PA, WILLIAMS TJ, HARDING SE, 1993. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: H176-H182.
3. CHUNG MK, GULICK TS, ROTONDO RE, SCHREINER GF, LANGE LG, 1990. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res 67: 753-763.
4. DIAMOND J, CHU EB, 1985. A novel cyclic GMP-lowering agent, LY83583, blocks carbachol-induced cyclic GMP elevation in rabbit atrial strips without blocking the negative inotropic effects of carbachol. Can J Physiol Pharmacol 63: 908-911.
5. DIAMOND J, TEN EICK RE, TRAPANI AJ, 1977. Are increases in cyclic GMP levels responsible for the negative inotropic effects of acetylcholine in the heart? Biochem Biophys Res Commun 79: 912-918.
6. EBINA T, TOYO Y, OKA N, SCHWENCKE C, KAWABE J-I, ISHIKAWA Y, 1997. Isoform-specific regulation of adenylyl cyclase by oxidized catecholamines. J Mol Cell Cardiol 29: 1247-1254.
7. ENDOH M, YAMASHITA S, 1981. Differential responses to carbachol, sodium nitroprusside and 8-bromo-guanosine 3′, 5′-monophosphate of canine atrial and ventricular muscle. Br J Pharmacol 73: 393-399.
8. FLESCH M, KILTER H, CREMERS B, LENZ O, SUDKAMP M, KUHN-REGNIER F, BOHM M, 1997. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmacol Exp Therap 281: 1340-1349.
9. GARTHWAITE J, SOUTHAM E, BOULTON CL, NIELSEN EB, SCHMIDT K, MAYER B, 1995. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48: 184-188.
10. HARRISON WH, WHISLER WW, HILL BJ, 1968. Catecholamine oxidation and ionization properties indicated from the H release, tritium exchange, and spectral changes which occur during ferricyanide oxidation. Biochemistry 7: 3089-3094.
11. HAYWOOD GA, TSAO PS, VON DER LEYEN HE, MANN MJ, KEELING PJ, TRINDADE PT, LEWIS NP, BYRNE CD, RICKENBACHER PR, BISHOPRIC NH, COOKE JP, MCKENNA WJ, FOWLER MB, 1996. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93: 1087-1094.
12. 2+ transients in ferret ventricular muscles. J Physiol Lond 461: 185-199.
13. 2+ channels by S-nitrosothiol nitric oxide donors. Circ Res 81: 742-752.
14. JOE EK, SCHUSSHEIM AE, LONGROIS D, MAKI T, KELLY RA, SMITH TW, BALLIGAND J-L, 1998. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. J Mol Cell Cardiol 30: 303-315.
15. KAYE DM, WIVIOTT SD, KOBZIK L, KELLY RA, SMITH TW, 1997. S-nitrosothiols inhibit neuronal norepinephrine transport. Am J Physiol 272: H875-H883.
16. KELLY RA, BALLIGAND J-L, SMITH TW, 1996. Nitric oxide and cardiac function. Circ Res 79: 363-380.
17. KOJDA G, KOTTENBERG K, NIX P, SCHLUTER K-D, PIPER HM, NOACK E, 1996. Low increases in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78: 91-101.
18. KOJDA G, KOTTENBERG K, NOACK E, 1997. Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts. Eur J Pharmacol 334: 181-190.
19. LINCOLN TM, KEELY SL, 1981. Regulation of cardiac cyclic GMP-dependent protein kinase. Biochim Biophys Acta 676: 230-244.
20. LUO D, DAS S, VINCENT SR, 1995. Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur J Pharmacol 290: 247-251.
21. MACDONELL KL, DIAMOND J, 1997. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle. Br J Pharmacol 122: 1425-1435.
22. MACDONELL KL, TIBBITS GF, DIAMOND J, 1995. cGMP elevation does not mediate muscarinic agonist-induced negative inotropy in rat ventricular cardiomyocytes. Am J Physiol 269: H1905-H1912.
23. MARKS GS, MCLAUGHLIN BE, JIMMO SL, POKLEWSKA-KOZIELL M, BRIEN JF, NAKATSU K, 1995. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholino-sydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate. Drug Metab Dispos 23: 1248-1252.
24. MOHAN P, BRUTSAERT DL, PAULUS WJ, SYS SU, 1996. Myocardial contractile response to nitric oxide and cGMP. Circulation 93: 1223-1229.
25. MORO MA, RUSSELL RJ, CELLEK S, LIZASOAIN I, SU Y, DARLEY-USMAR VM, RADOMSKI MW, MONCADA S, 1996. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA 93: 1480-1485.
26. NAWRATH H, BAUMNER D, RUPP J, OELERT H, 1995. The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium. Br J Pharmacol 116: 3061-3067.
27. SCHRAMMEL A, BEHRENDS S, SCHMIDT K, KOESLING D, MAYER B, 1996. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 50: 1-5.
28. SHAH AM, LEWIS MJ, HENDERSON AH, 1991. Effects of 8-Bromo-cGMP on contraction and on inotropic response of ferret cardiac muscle. J Mol Cell Cardiol 23: 55-64.
29. 2+ in intact cardiac myocytes. Circ Res 74: 970-978.
30. SMITH JA, SHAH AM, LEWIS MJ, 1991. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol 439: 1-14.
31. ++-dependent constitutive nitric oxide synthase is not involved in the cyclic GMP-increasing effects of carbachol in ventricular cardiomyocytes. J Pharmacol Exp Therap 266: 919-925.
32. UNGUREANU-LONGROIS D, BALLIGAND JL, KELLY RA, SMITH TW, 1995. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 27: 155-167.
33. WALDMAN SA, MURAD F, 1987. Cyclic GMP synthesis and function. Pharmacol Rev 39: 163-196.
34. WANG S, YAN L, WESLEY RA, DANNER RL, 1997. Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP. J Biol Chem 272: 5959-5965.
35. WATANABE AM, BESCH HR JR, 1975. Interaction between cyclic adenosine monophosphate and cyclic guanosine monophosphate in guinea pig ventricular myocardium. Circ Res 37: 309-317.
36. XU L, EU JP, MEISSNER G, STAMLER JS, 1998. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279: 234-237.
37. 2+ in cardiac myocytes. Circ Res 81: 1011-1020.